secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2025-12-02T23:59:59+00:00
Accession:  0001628908-25-000141
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health board adds Jill Smith as director; reaffirms Q4 guidance
-----------------------------------------------------------------------

- Cheryl Scott retired from Board on Dec 1, 2025; no disagreement; 21,979 RSUs accelerated.
- Jill Smith appointed to Board on Dec 2, 2025; term expiring at 2026 annual meeting; determined independent.
- Ms. Smith brings 25+ years of leadership; ex-CEO of DigitalGlobe, Allied Minds; current director at Securitas, Check Point, MDA Space.
- Reaffirmed Q4 2025 revenue guidance $462M-$472M and Adj. EBITDA $30M-$40M (unchanged from Nov 6).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890825000141/0001628908-25-000141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890825000141/evh-20251201.htm
  HTML page:      https://secwatch.observer/filing/0001628908-25-000141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer